NRC-2694
CAS No. 936446-61-6
NRC-2694 ( —— )
Catalog No. M26774 CAS No. 936446-61-6
NRC-2694 is an antagonist of the epidermal growth factor receptor (EGFR). It has anti-cancer and anti-proliferative properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 295 | In Stock |
|
10MG | 507 | In Stock |
|
25MG | 802 | In Stock |
|
50MG | 1107 | In Stock |
|
100MG | 1503 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNRC-2694
-
NoteResearch use only, not for human use.
-
Brief DescriptionNRC-2694 is an antagonist of the epidermal growth factor receptor (EGFR). It has anti-cancer and anti-proliferative properties.
-
DescriptionNRC-2694 is an antagonist of the epidermal growth factor receptor (EGFR). It has anti-cancer and anti-proliferative properties.(In Vitro):NRC-2694 (80 ng) induce comparable inhibition of EGFR expression.(In Vivo):NRC-2694 (10 mg/kg) regresses the tumor in mice. The maximum tolerated dose of NRC-2694 in male and female mice is 2000 mg/kg (p.o.), in toxicity studies .
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorInfluenza virus
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number936446-61-6
-
Formula Weight418.5
-
Molecular FormulaC24H26N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCCN1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.J V Tuttle, et al. Purine 2'-deoxy-2'-fluororibosides as antiinfluenza virus agents. J Med Chem
molnova catalog
related products
-
Afatinib dimaleate
An irreversible, dual EGFR/HER2 inhibitor with IC50 of 0.5/0.4/10/14 nM for wt EGFR/EGFR L858R/EGFR L858R+T790M/HER2 respectively.
-
AG-1557 hydrochlorid...
AG-1557 is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194).
-
Mobocertinib
Mobocertinib is a potent ?inhibitor of epidermal growth factor receptor (EGFR) and an antineoplastic agent.